Skip to main content
Equibles

AQR CAPITAL MANAGEMENT LLC

Position in LFCR — Lifecore Biomedical, Inc. De

CIK 1167557 Greenwich, CT
Back to LFCR Full portfolio

Position in LFCR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$291,966
+$232,932 QoQ
Shares Held
55,613
+250.4% QoQ
Ownership
0.147%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 98 holders
Holding Since
Sep 2020
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LFCR Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

AQR CAPITAL MANAGEMENT LLC holds $1,405,033,456 across 42 Drug Manufacturers - Specialty & Generic names. LFCR ranks #41 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NBIX
Neurocrine Biosciences Inc
 3,818,037 $643,491,951
2 UTHR
UNITED THERAPEUTICS Corp
 546,002 $295,840,259
3 ZTS
Zoetis Inc.
 1,070,929 $76,956,955
4 VTRS
Viatris Inc
 4,694,966 $74,556,056
5 PRGO
PERRIGO Co plc
 3,480,666 $36,164,117
6 LNTH
Lantheus Holdings, Inc.
 261,250 $28,983,071
7 IRWD
Ironwood Pharmaceuticals Inc
 6,465,921 $27,221,524
8 TAK
Takeda Pharmaceutical Co Ltd
 1,525,686 $24,456,745

All Filings in LFCR

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $291,966 55,613
2026-03-31 $59,034 15,870
2025-12-31 $132,277 16,171
2025-09-30 $92,712 12,597
2025-06-30 $92,980 11,451
2022-06-30 $217,166 21,782
2022-03-31 $589,132 50,875
2021-12-31 $676,911 60,983
2021-09-30 $549,548 59,604
2021-06-30 $635,973 56,531
2021-03-31 $651,698 61,481
2020-09-30 $200,795 20,658